StockData
Tenax Therapeutics, Inc. logo

Tenax Therapeutics, Inc. (TENX) stock

TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.25−0.14 (-10.07%)

Close on Nov 20, 2026Market cap $46.78MP/E –Yield –

Tenax Therapeutics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Tenax Therapeutics's gross profit for the twelve months ending Apr 30, 2015 was $0. For fiscal 2015 it was $0. The highest annual figure on record is $103.17K in fiscal 2011.

Annual gross profit

PeriodPeriod endValueChange
FY2015Apr 30, 2015$0–
FY2014Apr 30, 2014-$104.07K-309.9%
FY2013Apr 30, 2013$49.57K+0.6%
FY2012Apr 30, 2012$49.27K-52.2%
FY2011Apr 30, 2011$103.17K–

Quarterly gross profit

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2015CQ1 2015Apr 30, 2015$0–
Q3 FY2015CQ4 2014Jan 31, 2015$0–

More Tenax Therapeutics figures

See a number that looks wrong?